The genetic basis of feline leukemia virus (FeLV)-induced lymphoma was investigated in a series of 63 lymphoid tumors and tumor cell lines of presumptive T-cell origin. These were examined for virus-induced rearrangements of the c-myc,flvi-2 (bmi-1),fit-1, and pim-1 loci, for T-cell receptor (TCR) gene rearrangements, and for the presence of env recombinant FeLV (FeLV-B). The myc locus was most frequently affected in naturally occurring lymphomas (32%; n = 38) either by transduction (21%) or by proviral insertion (11%). Proviral insertions were also common atflvi-2 (24%). The two other loci were occupied in a smaller number of the naturally occurring tumors (fit-i, 8%; pim-i, 5%). Examination of the entire set of tumors showed that significant numbers were affected at two (19%Yo) or three (5%) of the loci. Occupation of the fit-i locus was observed most frequently in tumors induced by FeLV-myc strains, whileflvi-2 insertions occurred with similar frequency in the presence or absence of obvious c-myc activation. These results suggest a hierarchy of mutational events in the genesis of feline T-cell lymphomas by FeLV and implicate insertion atfit-i as a late progression step. The strongest links observed were with T-cell development, as monitored by rearrangement status of the TCR n-chain gene, which was positively associated with activation of myc (P < 0.001), and with proviral insertion at flvi-2 (P = 0.02). This analysis also revealed a genetically distinct subset of thymic lymphomas with unrearranged TCR ,8-chain genes in which the known target loci were involved very infrequently. The presence of env recombinant FeLV (FeLV-B) showed a negative correlation with proviral insertion at fit-i, possibly due to the rapid onset of these tumors. These results shed further light on the multistep process of FeLV leukemogenesis and the relationships between lymphoid cell maturation and susceptibility to FeLV transformation.
susceptibility to FeLV transformation.
Feline leukemia virus (FeLV) is a widespread, naturally occurring pathogen of the domestic cat population. The virus is associated with a range of neoplastic diseases in the field, the most common form of which is lymphosarcoma of T-cell origin. Early studies of these tumors showed that the c-myc gene was frequently affected by FeLV insertion or transduction (23, 31, 33) . The c-myc gene encodes a nuclear phosphoprotein belonging to a family of transcription factors which have similar basic helix-loop-helix domains and related DNA-binding motifs (2, 6, 27) . The expression of c-myc is a feature of proliferating cells of many lineages, and the loss of normal control of its expression predisposes to tumors of correspondingly diverse tissue origin, including a high proportion of lymphoid neoplasms (27) .
The significant causal role of myc in feline thymic lymphosarcomas was demonstrated by the capacity of the myctransducing viruses to reproduce the disease very rapidly (12 to 14 weeks) after inoculation into neonatal cats (22, 34) . However, further examination revealed that even the short-latency tumors induced by FeLV-myc recombinant viruses were of clonal origin and had phenotypic features which could not be reproduced by infection of T cells in vitro (34) . These observations led us and others to screen such tumors for genes which could collaborate with myc in the leukemogenic process.
By examining the sites of proviral insertion in tumors * Corresponding author. Phone: 41-330-5608. Fax: 41-330-5602. induced by FeLV-myc viruses, two loci of common insertion were identified. The first of these loci was flvi-2 (24) , which subsequently proved to be the feline homolog of bmi-1 (25) , a myc-collaborating gene previously identified as a common proviral insertion site in B-cell lymphomas of myc transgenic mice (E,u-myc) infected with Moloney murine leukemia virus (MuLV) (49) . The bmi-1 gene product is a representative of a novel nuclear protein family with characteristic helix-turn and zinc finger motifs (47) . Mice overexpressing bmi-1 are also predisposed to lymphomas, while cross-breeding with E,u-myc mice showed a synergistic effect, with tumors developing with higher frequency and after a shorter latent period (12) . The second common FeLV insertion locus to be identified in FeLV-myc tumors was fit-I (45) . This locus was mapped to feline chromosome B2, but its coding potential is as yet unknown. The feline homolog of another known myc-collaborating gene (pim-1) also maps to chromosome B2, but RNA analysis showed no evidence of long-range activation ofpim-1 in tumors with insertions at fit-i (45) . In the present study, a new feline pim-1 probe was generated and used to show that pim-1 is itself a common insertion locus for FeLV which is occupied in a small number of field case and FeLV-mycinduced lymphomas. Subgroup B FeLVs are generated from the common, horizontally transmissible, subgroup A form by recombination with endogenous proviral elements from which they acquire the 5' portion of env (21, 42) . This process is reminiscent of the generation of murine mink cell focus-forming (MCF) viruses from ecotropic MuLV (20 (16) . A recent study showed a very high prevalence of FeLV-B in tumor-bearing cats (39) , but since a PCR method was used, this would not readily distinguish between FeLV-B as an element in tumor DNA or as a minor contaminant arising from tumor infiltrates or adjacent tissues. In the present study, we reexamined this issue by blot hybridization of tumor DNA, using a subgroup B-specific probe (42) .
The principal aim of this study was to draw together and integrate diverse observations from a number of independent studies on the genetics of FeLV-induced lymphomas. With a similar aim, a recent study examined 21 thymic and multicentric lymphosarcomas for insertions at c-myc, flvi-2, and N-myc (26) . In the present study, we have examined a larger series (n = 63) for alterations of four insertion loci and tested these for association with each other, with a standard marker of T-cell maturation (rearrangement of T-cell receptor (23, 31, 33, 34, 44) , occupation of the flvi-2 locus (24, 26) , and occupation of the fit-i locus (45) . To this collection of tumors, a further series of 18 field case lymphomas was added. Although FeLV infection is associated with a wide range of malignant diseases (11, 15) , the present analysis was restricted to the most common form, lymphoma of presumptive T-cell origin (thymic or multicentric), and to those cases in which the integrated FeLV genome was present.
Probes. The c-myc locus was analyzed by using the P1 probe, a PstI-EcoRI fragment from FeLV-CT4 v-myc comprising mainly exon 3 sequences of c-myc (33) . The fit-i locus was analyzed with fit-i probe C, a 600-bp NcoI fragment derived from the major cluster of proviral insertions (unpublished data and references 45). The flvi-2 probe (probe F) was a PstIEcoRI fragment (see Fig. 2 ) (24) . TCR,B gene rearrangements were detected by using a 390-bp BglII fragment derived from the C,B domain of v-tcr (9, 44) .
Thepim-i probes were generated from feline genomic DNA by using the following primers: 5'-CGAGTGTA(CT)AG(TC) CCTCCAGAGTGG-3' and 5'-CTGAAGAGAC(AC)(GC)T (TC)TGCCTGAAG-3' to amplify feline pim-i exon 5; and 5'-CGTCATTAGACTTCTGGAC-3' and 5'-TCAAAGTCC GTGTAGACTG-3' for murine pim-i exon 4. In the presence of 1.5 mM MgCl2, genomic DNA at 10 ng/,l, and primers at 10 p,M, 30 cycles of denaturation (1 min, 94°C), annealing (1 min, 57°C) and extension (1 min, 72°C) were carried out. The 172-bp feline exon 5 and 299-bp murine exon 4pim-i products were subcloned into the plasmid vector pCRII.
Southern blot hybridization. DNA preparation, restriction enzyme digestion, agarose gel electrophoresis, and Southern blot hybridization analysis were all carried out as described rearranged allele was strongly represented, suggesting its occupation in all or most of the tumor cells. In contrast, in some cases (lanes c, d, and f), the rearrangement was present in only a proportion of the cells. The newly mapped insertions at fit-i are shown in Fig. 2 underneath the restriction map of the locus alongside the tumor identification code, with those mapped previously shown above the line. Extensive analysis of the locus around the major insertion cluster has not as yet revealed a transcription unit affected by these insertions. Proviral insertions at flvi-2. flvi-2, the feline homolog of bmi-1, was previously shown to be occupied in 13 independent cases of thymic or multicentric lymphoma (24, 26) . We examined a further 52 tumors and found a total of seven new examples of insertion which were mapped and tested for proviral orientation at the locus. Figure 1B shows the results of Southern blot hybridization analysis of six of the new cases which were mapped, alongside control tissues (lane C) and tumors without rearrangement at the locus (lane e). Again, the rearranged alleles coincided with U3-hybridizing fragments (not shown) and generated restriction maps consistent with proviral insertion at the site. The intensity of the rearranged alleles shown in Fig. 1B indicates that the rearrangement was carried by most or all of the cells in the tumor mass. Thus, in tumor F422-1T (Fig. 1A and B, lanes g ), the major tumor cell population contains insertions at both fit-1 andflvi-2 as well as the integrated FTl v-myc gene. Figure 2 shows the locations of the flvi-2 insertions mapped previously (above the line) alongside the new examples (below the line). In common with previous findings (24, 26) , the predominant observation was of insertion downstream and in the same orientation as the transcription unit, although there did appear to be a slight shift toward the gene in the major cluster of insertions. Whether this difference is significant or merely the result of mapping with a different flvi-2 fragment (probe F places most of the insertions 3' to the adjacent HindIII site) remains to be established.
As seen in Table 1 , the overall frequencies offlvi-2 involvement are similar in the natural and experimentally induced tumors and were also observed in a tumor (TlOT; Fig. 2 ) induced by FeLV-Rickard, a highly oncogenic strain which was selected by in vivo passage of thymic tumor extracts (38) but does not contain a v-myc gene (10, 33) .
Proviral insertions at the pim-1 gene. The pim-1 gene encodes a cytoplasmic protein kinase and is well established as an oncogene which can collaborate with c-myc in T-cell neoplasia (4, 50) . In common with the fit-i locus, the feline pim-1 gene is located on chromosome B2. To clarify the relationship between the two loci, we examined the prevalence and pattern of FeLV insertion at pim-1. Although murine pim-1 probes hybridize with feline DNA, the signal is generally weak and requires low-stringency washing conditions. To generate a feline pim-1 probe, primers were designed on the basis of conservation of the murine and human pim-] genes and used to amplify a 172-bp probe from exon 5 which shares 93.6% homology with humanpim-1 and 90.1% with the murine sequence. With this probe, it was possible to detect rearrangements of the locus sensitively under high-stringency hybridization conditions. Figure 1C shows two tumors carrying rearrangements at the pim-1 locus detected by digestion of DNA from tumor (lane T) and control (lane C) tissue with EcoRV. As can be seen from the blots, the rearranged allele is at least as intense as or more intense than its normal counterpart (J51-3), suggesting that either amplification of the rearranged locus or loss of the normal allele had occurred. Interestingly, tumor J51-3 also had a rearrangement atfit-1 (Fig. 1A, lane d) .
However, the low representation of the rearranged fit-i allele in this case suggests that this was present in a subset of the tumor cells which carried both FeLV v-myc and a rearranged pim-1 gene.
Attempts to amplify feline pim-1 exon 4 by the same approach were unsuccessful, but a murine exon 4 probe was amplified (see Materials and Methods) and used to orient the feline gene map. It was therefore possible to place the three proviral insertions detected on this outline map (Fig. 2) . The orientation of the inserted elements has not yet been determined, but assuming that the architecture of the gene locus is also conserved, these correspond to insertions at the 5' end (84904 and J51-3) and 3' end (C2) of the transcription unit.
Concerted gene rearrangements in feline T-cell tumors. The number of tumors in which one or more of the four loci was involved is shown in the two Venn diagrams in Fig. 3 . Figure  3A includes tected in a significant number of tumors in both groups. Not surprisingly, the number of tumors for which at least one event was scored was significantly higher in group B, in which a v-myc gene was introduced with the inoculum. However, the subset of group A tumors which had activated myc also showed a high score for secondary events, and this subset was not significantly different from that for group B, even for the number of tumors involving three hits (3 of 15 compared with 0 of 16; P > 0.10). This observation suggests that we have not selected for an unnatural set of gene activation events by inducing lymphomas with FeLV-myc isolates.
The group A tumors also included eight cases in which insertions at flvi-2, fit-i, or pim-1 occurred in the absence of any detectable abnormality of the c-myc locus. Overall, only fit-i insertion was strongly associated with myc activation (P = 0.04). However, this association was due mainly to the high incidence offit-i insertions in group B tumors. The occurrence of field case lymphoma in which the only identified genetic lesion was an insertion at fit-i suggests that the association is not obligatory.
TCRII gene rearrangements in feline lymphomas. Rearrangement of the TCR, gene is a crucial commitment point in the thymic development of the major a,B T-cell lineage (30) , and the detection of a unique rearrangement of the TCRPi gene is widely used as a marker of clonality for tumors of T-cell origin. The possibility that the T-cell repertoire plays an even more significant and direct role in oncogenesis was suggested by the transduction by FeLV of a full-length, functionally rearranged TCR1 gene in a naturally occurring thymic lymphosarcoma (9) . In the same tumor, there was a separate population of proviruses which contained a transduced myc gene, suggesting the possibility of oncogenic cooperation between myc and an activated TCR (9, 44) .
The relationship between T-cell genotype and other genetic markers was examined further in the present tumor series. The TCR,B locus was examined by Southern blot hybridization using a C1-specific probe (44) . Digestion with EcoRI generates a 22-kb fragment spanning C,1l and CP2, while digestion with HinclI separates these tandemly duplicated elements into 9.4-kb (C,11) and 3-kb (C,B2) fragments. As shown in the examples in Fig. 4 , comparison of tumor DNA with uninvolved control tissue revealed whether the genes were in germ line configuration or rearrangement had taken place. Also, the presence of a non-germ line fragment at high intensity in tumor T15 (arrowed) revealed the presence of a clonal cell population carrying a unique rearrangement.
The lineage and differentiation state of the 20 tumors with TCR13 in germ line configuration remains undetermined. Given the thymic lymphoid origin of many of these tumors, it is possible that these arise from immature cells which have not yet commenced TCR rearrangement or alternatively from a distinct non-ac lineage such as -yl T cells (36) . Clonal rearrangement of the immunoglobulin heavy-chain gene was observed in only two of these tumors (not shown). Table 2 lists the numbers and percentages of tumors positive for each of the other parameters when the tumor panel is subdivided on the basis of TCR,B rearrangement. Inspection of these data suggests that c-myc, flvi-2, and fit-i are positively associated with TCR1 rearrangement. Statistical analysis shows that association is significant only for the first two of these (P < 0.001 and P = 0.020, respectively). Although a similar trend for fit-i appears to be emerging, with the small numbers involved, this does not attain statistical significance (P = 0.12). (20) 2 (10)a 1 (5) 1 (5) 2 (10) 11 (58) a Very highly significant difference (P < 0.001, x2 test with Yates correction).
b Significant difference (P = 0.020, Fisher's exact test).
Occurrence of recombinant FeLV-B proviruses in tumor DNA. Subgroup B viruses invariably derive the 5' portion of their env gene from endogenous FeLV sequences by recombination (21, 35, 39, 42) . Using a probe (B/S) derived from this portion of the FeLV-B genome, it is possible to screen cells for the presence of FeLV-B by blot hybridization. Digestion of feline cell DNA with KpnI and probing with B/S at high stringency reveals the presence of exogenous FeLV-B as a novel hybridizing fragment which is distinguished from endogenous FeLV sequences by its unique size and its absence from uninfected cell DNA (42) .
We compared tumor and uninvolved tissues from each case and scored a positive result for FeLV-B wherever such a novel fragment was seen. Examples of these analyses are shown in Fig. 5 , in which only tumor TR3 has the typical exogenous FeLV-B env fragment of 3.7 kb. Table 3 lists the numbers and percentages of tumors positive for each of the other parameters when the tumor panel is subdivided on the basis of detection of a FeLV-B recombinant. As can be seen, the other parameters are distributed relatively evenly between the two subsets, with the exception of insertion at fit-i, which is negatively associated with the presence of FeLV-B (P = 0.001, Fisher's exact test).
However, further insight into the possible basis of this relationship is revealed in Table 1 , in which the tumors are subdivided according to the mode of their induction. It is evident that the discordance is due mainly to the rapidly arising 
DISCUSSION
This study extends previous observations on the high frequency of c-myc gene activation by FeLV in naturally occurring tumors (32%). The incidence of proviral insertions at flvi-2 in a series of 38 naturally occurring tumors was almost as high (24%). Analysis of this larger series of tumors also confirmed the lack of a strong association between these two gene activation events (26) . This observation is somewhat surprising in view of the demonstrated ability of myc and bmi-i genes to collaborate in transgenic mice (12) , and it would appear that both myc and bmi-i are relatively promiscuous in their ability to act in concert with other genes. In contrast, occupation of the fit-i locus was most commonly seen in tumors with activated myc and appeared in some cases to affect only minor tumor cell populations. The oncogenic potential of fit-i insertion may be expressed only when c-myc or a related gene is activated, a scenario which would occur readily in the tumors where an active myc-oncogene was introduced with the viral inoculum. An appreciation of the functional basis of this association will require identification and characterization of the transcription unit affected byfit-i insertions, but it appears likely that the occupation of fit-i is often a late step in tumor development.
Our analysis indicates that each of the four insertion loci studied here can contribute to the neoplastic state independently of the others and that no combination of two events is obligatory. The finding that several tumors had concomitant alterations at three different loci (c-myc and two others) is in line with models of leukemogenesis by murine retroviruses in which a requirement for three to six hits has been postulated (49) . Also, we noted a higher frequency of two or three recorded hits in the tumors induced experimentally by FeLVmyc viruses. It would appear that the introduction of a transduced myc allele with the inoculum virus not only shortens the latent period required for tumor induction (34) but increases the probability of detecting concerted gene rearrangements. This observation is analogous to studies of virusaccelerated tumors of oncogene transgenic mice in which proviral tagging has been used to show high frequency targeting of collaborating genes (49, 50 (17) , the frequent but not universal detection of FeLV-B in tumor DNA could thus be explained. Also, the introduction of an activated myc gene with the FeLV-myc viruses would reduce by at least one the number of insertions required to complete the transformation process, further relieving the requirement for FeLV-B.
Although this seems to us the most likely explanation, it must be acknowledged that a more positive role or conversely an innocent bystander role for FeLV-B cannot be excluded. Also, the dissemination of FeLV-B in vivo may be slow (18, 46) and constrained by interference due to endogenous FeLV env gene expression in normal lymphoid cells (28) .
In conclusion, the pattern of proviral insertion and gene activation in feline T-cell lymphomas suggests that a pool of genes is involved which is significantly larger than that currently known. In particular, the subset of thymic tumors which lack rearrangement of TCRI genes show only a low incidence of involvement of the known target genes and are ripe for further for genetic analysis. Also, the activation in feline tumors of genes homologous to two established myc-collaborating genes of the mouse (bmi-1 and pim-1) indicates crossspecies conservation of their oncogenic functions and should serve as a further stimulus to examine their roles in human hemopoietic malignancies.
